20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
AUGMENTED COGNITIVE TRAINING
#3902ANTICANCER AGENT
#3903Augmented cognitive training
#3904Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases
#3905IMMUNOSUPPRESSIVE BLOOD CELLS AND METHODS OF PRODUCING THE SAME
#3906Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins
#3907Therapeutic agent for hematopoietic tumors
#3908Expanding the eukaryotic genetic code
#3909METHOD OF PROTECTING CELLS
#3910Methods for treating heat stress and related compositions
#3911METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVIOUS SYSTEM SITES
#3912Methods and Systems for Treatment of Neurological Diseases of the Central Nervous System
#3913WNT3A FOR INHIBITION OF SCARRING
#3914Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
#3915OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING PEPTIDES AS PRESERVATIVE
#3916High-density lipoprotein coated medical devices
#3917METHOD FOR ENHANCING AN IMMUNE RESPONSE
#3918KRÜPPEL-LIKE FACTORS AND FAT REGULATION
#3919SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS
#3920Selectively targeted antimicrobial peptides and the use thereof
#3921COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY
#3922COMBINATION THERAPY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE, AND KIT THEREFOR
#3923THERAPEUTIC AGENT FOR ACUTE HEPATITIS OR PROPHYLACTIC/THERAPEUTIC AGENT FOR FULMINANT HEPATITIS
#3924Myeloid protein activation of anti-inflammatory and anti-hypoxic pathway
#3925LACTATION-ASSOCIATED POLYPEPTIDES
#3926Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist
#3927DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE (AD)
#3928APLS FOR TREATING ARTHRITIS
#3929Use of apolipoproteins to decrease inflammation
#3930COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
#3931METHODS TO IDENTIFY FACTORS ASSOCIATED WITH MUSCLE GROWTH AND USES THEREOF
#3932METHODS OF INDUCING PLURIPOTENCY INVOLVING OCT4 PROTEIN
#3933METHODS OF INDUCING PLURIPOTENCY INVOLVING SOX2 PROTEIN
#3934Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#3935Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia
#3936Treatment of endothelial dysfunction in diabetic patients
#3937METHODS FOR TREATING ERECTILE DYSFUNCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES
#3938Polynucleotides encoding recombinant lubricin molecules and uses thereof
#3939Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-37
#3940METHODS FOR P2RY5 MEDIATED REGULATION OF HAIR GROWTH AND MUTANTS THEREOF
#3941Chronic lymphocytic leukemia prognosis and treatment
#3942Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
#3943Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells
#3944METHOD FOR IMPROVING NEUROTRANSMISSION FAILURE USING A NOVEL AGENT
#3945Biglycan and related therapeutics and methods of use
#3946Treatment of mood and anxiety disorders
#3947Methods for modulating angiogenesis via dystrophin Dp71
#3948Methods and compositions for the reduction of neutrophil influx and the treatment of bronchopulmonary displasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
#3949PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES ASSOCIATED WITH EYE DISEASE
#3950Peptide compositions and therapeutic uses thereof
#3951Biomarkers for painful intervertebral discs and methods of use thereof
#3952Use of Afamin for Treating Fertility Disorders
#3953Inhibition of interaction of PSD93 and PSDS95 with nNOS and NMDA receptors
#3954Use Of SCO-Spondin Peptides For Inhibiting Or Preventing Neuronal Apoptosis Mediated By Cell Death Receptor Ligands
#3955OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT
#3956Regulation of BACE degradation
#3957Cytokine induction of selectin ligands on cells
#3958METHODS FOR INCREASING EXPRESSION OF SERCA2A IN CARDIAC MUSCLE
#3959NOVEL STRA6 POLYPEPTIDES
#3960Heat shock protein GP96 vaccination and methods of using same
#3961COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES
#3962Method for Regulating Production of Hemoglobin Beta Chains
#3963Compositions and methods of using proislet peptides and analogs thereof
#3964Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
#3965Stabilization of hypoxia inducible factor (HIF) alpha
#3966THERAPEUTIC AGENT AND DETECTION REAGENT FOR ARTERIOSCLEROTIC DISEASE WHICH TARGETS FOR SALUSIN
#3967PROTOCOLS FOR TREATING AND PREVENTING OBESITY AND COMPLICATIONS ARISING THEREFROM
#3968METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY
#3969PSMA antibodies and uses thereof
#3970COMPOSITION COMPRISED OF AKAP12 AND USES OF AKAP12 MUTANT ZEBRAFISH AS AN ANIMAL MODEL
#3971Alpha B-crystallin as a therapy for multiple sclerosis
#3972METHODS AND COMPOSITIONS FOR TREATING ORAL AND ESOPHAGEAL LESIONS
#3973Methods for Modulating a PDGF-AA Mediated Biological Response
#3974USE OF STRAINS OF LACTOBACILLUS AND BY-PRODUCTS THEREOF FOR INHIBITING FORMATION OF BLOOD VESSELS
#3975Recombinant alpha-fetoprotein and compositions thereof
#3976METHODS AND REAGENTS FOR VACCINATION WHICH GENERATE A CD8 T CELL IMMUNE RESPONSE
#3977USE OF MEGANUCLEASES FOR INDUCING HOMOLOGOUS RECOMBINATION EX VIVO AND IN TOTO IN VERTEBRATE SOMATIC TISSUES AND APPLICATION THEREOF
#3978Use of angiogenin or angiogenin agonists for treating diseases and disorders
#3979Method of reducing total cholesterol level by administering matrilin-2 polypeptide
#3980IDENTIFICATION AND USE OF COMPOUNDS FOR TREATING PERSISTENT PAIN
#3981Composition and method for the treatment or prevention of spinal disorders
#3982LIGATION OF STAPLED POLYPEPTIDES
#3983Method for using HIP/PAP polypeptide composition for liver regeneration and prevention of liver failure
#3984Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same
#3985Compositions and methods for reprogramming eukaryotic cells
#3986Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication
#3987METHODS OF TREATING COGNITIVE IMPAIRMENT
#3988Methods and compositions for modulating PD1
#3989INFANT NUTRITIONAL COMPOSITIONS FOR PREVENTING OBESITY
#3990PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE
#3991Use of Idbf
#3992ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
#3993ALPHA CONNEXIN C-TERMINAL (ACT) PEPTIDES FOR TREATING AGE-RELATED MACULAR DEGENERATION
#3994DEFENSINS FOR TREATMENT OF INFECTIVE ENDOCARDITIS
#3995Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same
#3996COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE
#3997Immunotherapies employing self-assembling vaccines
#3998REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO
#3999Use of heat-shock protein 27 for cardiovascular disease prevention and treatment
#4000Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination
#4001NOVEL COMPOUNDS FOR MODULATING NEOVASCULARISATION AND METHODS OF TREATMENT USING THESE COMPOUNDS
#4002METHODS AND COMPOSITIONS FOR TREATING FUS1 RELATED DISORDERS
#4003Method for modulating appetite
#4004TREATMENT OF LIQUID CANCERS
#4005Methods and compositions for modulating adipocyte function
#4006USE OF RGM AND ITS MODULATORS
#4007Compositions and methods for modulating the immune system
#4008USE OF GLIS3 FOR PREPARING FUNCTIONAL PANCREATIC BETA-CELLS
#4009Novel genes and markers in type 2 diabetes and obesity
#4010Novel genes and markers in type 2 diabetes and obesity
#4011Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#4012Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
#4013Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer and skin lesions
#4014METHOD FOR ALLEVIATING PAIN USING PROTEIN ASSOCIATED WITH MYC AND RELATED COMPOUNDS, AND ASSAYS FOR IDENTIFYING SUCH COMPOUNDS
#4015ANTI-APOPTOTIC GENE SCC-S2 AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF
#4016Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
#4017Method of inhibiting platelet aggregation and clot formation
#4018USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES
#4019mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION
#4020COMPOSITIONS AND METHODS FOR THERAPEUTIC USE
#4021Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
#4022THERAPEUTIC USES OF COLOSTRININ
#4023Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue
#4024Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis
#4025Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#4026METHOD AND COMPOUND FOR THE TREATMENT OF VALVULAR DISEASE
#4027Vitamine B12 - Peptide Conjugates for Oral Delivery
#4028Composition for treating virus infection disease comprising Jab1
#4029Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
#4030Compositions and methods for reducing scar formation in wound healing
#4031ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF
#4032Proteins and methods for modulating cell activity
#4033Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents
#4034FUSION PROTEINS
#4035METHODS FOR TREATING A KIDNEY INJURY
#4036Fibromodulin formulation for reducing corneal scarring
#4037METHODS TO INCREASE PERMEABILITY OF CORNEAL EPITHELIUM AND DESTABILIZE STROMAL COLLAGEN FIBRIL NETWORK
#4038Compositions and methods for tissue engineering, tissue regeneration and wound healing
#4039Chimeric peptides comprising HER-2 B-cell epitopes and T-helper epitopes
#4040Compositions and Methods to Inhibit HPV Infection
#4041STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
#4042Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases
#4043Restoration of hearing loss
#4044Engineered zinc finger proteins for treating trinucleotide repeat disorders
#4045Method of inhibiting inflammation in a mammal by administering Bcl protein
#4046HISTONE OCTAMERS FOR INCREASED NUCLEIC ACID TRANSFER
#4047Means and Methods for Influencing Electrical Activity of Cells
#4048USE OF HNF4ALPHA FOR TREATMENT OF HUMAN MALIGNANT SOLID TUMORS THROUGH INDUCTION-DIFFERENTIATION THERAPY
#4049Cell proliferation reducing cancer specific PCNA peptides
#4050Method for treating stroke via administration of NEP1-40 and inosine
#4051COMPOSITIONS FOR TISSUE REPAIR/REGENERATION
#4052USE OF SURVIVIN TO TREAT KIDNEY FAILURE
#4053Use of immunesuppressant receptor
#4054NP1 ACTIVITY REGULATING ELEMENTS USEFUL FOR THE PRODUCTION OF DRUGS FOR THE TREATMENT OR PREVENTION OF HUMAN NEURODEGENERATIVE DISEASES, RESULTING DRUGS AND USE THEREOF
#4055Therapeutic modulation of ocular surface lubrication
#4056Methods of inhibiting tumor cell proliferation
#4057Methods of reducing excitotoxicity-induced retinal ganglionic neuron degeneration by an orthodenticle HOMOLOG2 (OTX2) homeoprotein
#4058Method for opening tight junctions
#4059IMMUNOGENIC TREATMENT OF CANCER BY PEPTIDES INDUCING THE PLASMA MEMBRANE EXPOSURE OF ERP57
#4060Compositions for treating dry eye disease
#4061Compositions and methods for promoting wound healing and tissue regeneration
#4062Protein involved in ovarian cancer
#4063Treatment of muscular dystrophies and related disorders
#4064USE OF PODOCAN PROTEIN IN TREATING CARDIOVASCULAR DISEASES
#4065Filipil compositions and methods for treating cancer
#4066Prodrug comprising a drug linker conjugate
#4067Polynucleotides encoding signal peptide-containing molecules
#4068COMPOSITIONS AND METHODS FOR TREATING DIABETES USING LISOFYLLINE ANALOGS AND ISLET NEOGENESIS ASSOCIATED PEPTIDE
#4069GONADAL FUNCTION IMPROVING AGENTS
#4070Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy
#4071Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
#4072Combination of a light ray with a cytochrome C oxidase substrate particularly for improving the appearance of the skin and/or hair
#4073Compound, use and method
#4074Polypeptide-polymer conjugates and methods of use thereof
#4075PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DRY EYE
#4076NELL-1 ENHANCED BONE MINERALIZATION
#4077METHODS OF TREATING CARDIAC DISORDERS
#4078Vascular targets for detecting, imaging and treating neoplasia or neovasculature
#4079COMPOSITIONS, METHODS AND KITS FOR DETECTING AND TREATING CANCER
#4080FUSION PEPTIDE THERAPEUTIC COMPOSITIONS
#4081Compositions and methods for inhibiting cell migration
#4082PARASPORIN-1 RECEPTOR AND USE THEREOF
#4083Treatment of synucleinopathies
#4084Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
#4085Compositions and methods modulating MG29 for the treatment of diabetes
#4086ACTIVE AGENTS, COMPOSITIONS, AND METHODS FOR INHIBITING AND REVERSING PLATELET FUNCTION
#4087Truncated activin type II receptor and methods of use
#4088METHODS AND COMPOSITIONS FOR BONE HEALING BY PERIOSTIN
#4089AGENTS AND METHODS FOR TREATMENT OF ANXIETY DISORDERS
#4090PROTEINS EZRIN, SERPIN B5, PEROXIREDOXIN-2 AND HEAT SHOCK PROTEIN BETA-1 AS AUTOANTIGENS FOR PSORIASIS VULGARIS AND POSTSTREPTOCOCCAL DISEASES
#4091Method and pharmacological composition for the diagnosis and treatment of male
#4092Cardiovascular therapy compositions
#4093METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION
#4094METHODS FOR TREATING AND LIMITING FIBROTIC DISORDERS AND KELOIDS
#4095METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF
#4096MEANS AND METHODS FOR THE SPECIFIC INHIBITION OF GENES IN CELLS AND TISSUE OF THE CNS AND/OR EYE
#4097Conjugate comprising P21 protein for the treatment of cancer
#4098APOPTOTIC PATHWAY TARGETING FOR THE DIAGNOSIS AND TREATMENT OF CANCER
#4099METHODS FOR TREATING OR PREVENTING HEART FAILURE
#4100Manufacture of factor H (FH) and FH-derivatives from plasma
#4101Method and compositions for prevention and treatment of diabetic and aged skin
#4102ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE
#4103Methods of suppressing microglial activation
#4104Oligopeptidic compounds and uses thereof
#4105COMPOSITIONS AND METHODS OF USE FOR POST-RADIATION PROTECTION
#4106Antitumor effect of mutant Bik
#4107Cystinosin replacement factor
#4108Adrenergic stimulation mediates hypersensitivity by inducing nerve growth factor expression
#4109METHODS AND COMPOSITIONS FOR TREATING NEURONAL DAMAGE OR DEGENERATION
#4110PHARMACEUTICAL COMPOSITIONS AND METHODS USING SECRETED FRIZZLED RELATED PROTEIN
#4111Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#4112Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy
#4113METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY
#4114Pre-transplant accomodated organs resistant to anti-donor immunity
#4115RECOMBINANT NEWCASTLE DISEASE VIRUS
#4116Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders
#4117Simple design to make solar water heating affordable and compatible with conventional water heaters
#4118Lipid formulated dsRNA targeting the PCSK9 gene
#4119METHODS FOR PREVENTING AND TREATING ALZHEIMER'S DISEASE (AD)
#4120Modulation of GLUT4 Gene Promoter activity BY AHNAK
#4121BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF
#4122PREVENTION AND TREATMENT OF ISCHEMIA-REPERFUSION INJURY AND RELATED CONDITIONS
#4123Carbon nanotube compositions and methods of use thereof
#4124CYTOKINE RECEPTOR MODULATORS, METHOD OF IDENTIFYING SAME, AND METHOD OF MODULATING CYTOKINE RECEPTORS ACTIVITY WITH SAME
#4125Use of FLJ25416 gene
#4126Hypoxia induced mitogenic factor
#4127Compositions and methods for immortalizing cells and screening for anti-cancer agents
#4128Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia
#4129MODULATORS OF PARAPTOSIS AND RELATED METHODS
#4130Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis
#4131STEM CELL DERIVED FACTORS FOR TREATING PATHOLOGIC CONDITIONS
#4132METHOD OF INCREASING METABOLISM
#4133Compositions and methods for treating and preventing heart tissue degeneration and uses thereof
#4134STEM CELLS FOR USE IN LOCATING AND TARGETING TUMOR CELLS
#4135Decoy-containing pharmaceutical compositions and method of using the same
#4136COMPOSITIONS AND METHODS FOR TREATING DIABETES USING LISOFYLLINE AND ISLET NEOGENESIS ASSOCIATED PEPTIDE
#4137Methods of screening for a compound that reduces atherogenesis
#4138PREDICTING AMD WITH SNPS WITHIN OR NEAR C2, FACTOR B, PLEKHA1, HTRA1, PRELP, OR LOC387715
#4139KLOTHO PROTEIN AND RELATED COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF CANCER
#4140Uses of Sperm Membrane Protein OBF
#4141ASSESSING SUSCEPTIBILITY TO VASCULAR DISORDERS
#4142Lipid formulation
#4143Cell permeable Nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same
#4144Casein Derived Peptides And Uses Thereof
#4145Isolated BRCA1 peptides and method of use
#4146Regulation of skin characteristics by DICKKOPF1 (DKK1)
#4147Novel Peptides and Their Use for the Treatment of Edema
#4148Compositions and methods for treatment of angiogenesis in pathological lesions
#4149Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders
#4150Compositions suitable for treatment of spinal disease, disorder or condition
#4151Methods of treatment using a vector encoding p21/
#4152Use of soluble CEACAM8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
#4153Paralytic peptide for use as a insecticide
#4154Methods of inhibiting calcineurin with ApoE analogs
#4155treatment
#4156GENES AND POLYMORPHISMS ASSOCIATED WITH AMD
#4157Method of selecting stem cells having high chondrogenic differentiation capability
#4158Methods to treat symptoms of pathophysiology related to body mass
#4159Use of an agent that restores tissue perfusion and oxygenation
#4160Casein Derived Peptides And Uses Thereof in Therapy
#4161Synthetic apolipoprotein E mimicking polypeptides and methods of use
#4162BRI POLYPEPTIDES AND REDUCING AB AGGREGATION
#4163DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDE INHIBITORS
#4164INDUCING IMMUNE-MEDIATED TUMOR CELL DEATH
#4165Methods for Modulating Apoptosis in Platelets
#4166COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS
#4167Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin
#4168Protein Mixture and Use Thereof in the Preparation of a Product that is Intended for Oral or Enteral Administration
#4169Modulation of the Neuroendocrine System as a Therapy for Motor Neuron Disease
#4170REDUCER OF IMMUNOSUPPRESSION BY TUMOR CELL AND ANTITUMOR AGENT USING THE SAME
#4171Compounds and methods for the treatment of vascular disease
#4172Method of treating peripheral vascular diseases using IL-18 inhibitors
#4173Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
#4174Myelin basic protein peptide composition
#4175Use of antisecretory factor
#4176Methods of Modulating Prokineticin 2 for Treatment of Stress Response and Anxiety-Related Disorders
#4177MILK PROTEIN COMPOSITION AND USE THEREOF
#4178Hox Compositions and Methods
#4179Method of treating a disease or condition characterized by aberrant epithelial cell proliferation
#4180Antibodies to tumor associated proteins
#4181Voltage gated calcium channel β-subunit anchoring regulator protein and uses thereof
#4182COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AGING-ASSOCIATED DISEASES
#4183Oncolytic virus
#4184Method for inducing lymphoid tissue and modulating intestinal homeostasis
#4185Apolipoprotein A-I mimics
#4186METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE
#4187Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof
#4188Method of Cancer Treatment with Antagonists of FAS Inhibitors
#4189Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains
#4190IBUDILAST AND IMMUNOMODULATORS COMBINATION
#4191ROLE FOR SRY IN PARKINSON'S DISEASE
#4192Methods and kits for treating fractures with a biological agent
#4193THERAPEUTIC AGENT COMPRISING LIPOCALIN 2 AGAINST CANCER METASTASIS, AND METHODS OF EARLY DIAGNOSIS AND INHIBITION OF CANCER METASTASIS USING LIPOCALIN 2
#4194Regulation of immune responses by modulation of the function of antigen presenting cells
#4195TUMOR ANTIGEN PROTEIN AND USE THEREOF
#4196Method for treating symptoms of diabetes
#4197Remedy for the treatment of cardio-vascular diseases or disorders
#4198NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
#4199Alpha-fetoprotein peptides and uses thereof
#4200Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof